Correct, not for mass market and not because it does not want to compete with Exact Sciences @josiejow37
Exact Sciences as we speak developing it's own CRC blood test.
@goedy pretty sure you doubted the company commercialising. They have apparently closed trial.
Overall 98% sensitivity and 91% specificity.
Advanced Adenoma's sensitivity - pick a number
US based company with better results launching world wide, page-63
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 105913 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 18707 | 1 |
View Market Depth
| Last trade - 07.00am 05/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable